ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 148 filers reported holding ACCELERON PHARMA INC in Q4 2016. The put-call ratio across all filers is 3.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $96,383,000 | +70.3% | 560,040 | +24.2% | 0.23% | +69.9% |
| Q2 2021 | $56,607,000 | -10.7% | 451,087 | -3.5% | 0.14% | -16.0% |
| Q1 2021 | $63,417,000 | -46.1% | 467,645 | -49.1% | 0.16% | -47.9% |
| Q4 2020 | $117,572,000 | +1.0% | 918,965 | -11.1% | 0.31% | -16.2% |
| Q3 2020 | $116,354,000 | +340.0% | 1,033,984 | +272.5% | 0.37% | +298.9% |
| Q2 2020 | $26,447,000 | +14.7% | 277,597 | +8.2% | 0.09% | -8.8% |
| Q1 2020 | $23,062,000 | +224.0% | 256,617 | +106.3% | 0.10% | +410.0% |
| Q3 2018 | $7,118,000 | +28.3% | 124,385 | +8.8% | 0.02% | +25.0% |
| Q2 2018 | $5,547,000 | +21.8% | 114,334 | -1.9% | 0.02% | +14.3% |
| Q1 2018 | $4,556,000 | +32.3% | 116,514 | +43.6% | 0.01% | +40.0% |
| Q4 2017 | $3,443,000 | +11.0% | 81,132 | -2.4% | 0.01% | +11.1% |
| Q3 2017 | $3,102,000 | +16.0% | 83,104 | -5.5% | 0.01% | +12.5% |
| Q2 2017 | $2,673,000 | +12.9% | 87,943 | -1.7% | 0.01% | +14.3% |
| Q1 2017 | $2,367,000 | +2.6% | 89,431 | -1.1% | 0.01% | 0.0% |
| Q4 2016 | $2,308,000 | -60.9% | 90,431 | -44.5% | 0.01% | -61.1% |
| Q3 2016 | $5,901,000 | +19.8% | 163,045 | +12.5% | 0.02% | +20.0% |
| Q2 2016 | $4,925,000 | +48.7% | 144,933 | +15.5% | 0.02% | +50.0% |
| Q1 2016 | $3,311,000 | -55.1% | 125,464 | -17.0% | 0.01% | -54.5% |
| Q4 2015 | $7,374,000 | +277.6% | 151,240 | +92.8% | 0.02% | +266.7% |
| Q3 2015 | $1,953,000 | -62.3% | 78,425 | -52.1% | 0.01% | -57.1% |
| Q2 2015 | $5,180,000 | -64.2% | 163,697 | -57.0% | 0.01% | -62.2% |
| Q1 2015 | $14,488,000 | +51.2% | 380,669 | +54.8% | 0.04% | +54.2% |
| Q4 2014 | $9,580,000 | +269.7% | 245,902 | +187.0% | 0.02% | +300.0% |
| Q3 2014 | $2,591,000 | -68.4% | 85,667 | -64.5% | 0.01% | -33.3% |
| Q2 2014 | $8,200,000 | +115.3% | 241,366 | +118.7% | 0.01% | 0.0% |
| Q1 2014 | $3,808,000 | -3.1% | 110,365 | +11.3% | 0.01% | 0.0% |
| Q4 2013 | $3,928,000 | – | 99,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |